BR100 Increased By (0.21%)
BR30 Increased By (0.98%)
KSE100 Increased By (0.07%)
KSE30 Decreased By (-0.15%)
BECO 5.64 Decreased By ▼ -0.07 (-1.23%)
BML 59.61 Increased By ▲ 0.90 (1.53%)
BOP 36.12 Decreased By ▼ -0.26 (-0.71%)
CNERGY 8.50 Increased By ▲ 0.17 (2.04%)
DCL 11.72 Decreased By ▼ -0.14 (-1.18%)
FCCL 58.47 Increased By ▲ 0.96 (1.67%)
FCSC 5.37 Decreased By ▼ -0.05 (-0.92%)
FFL 18.30 Increased By ▲ 0.24 (1.33%)
FNEL 1.32 Decreased By ▼ -0.02 (-1.49%)
HUMNL 11.55 Decreased By ▼ -0.12 (-1.03%)
KEL 8.36 Increased By ▲ 0.22 (2.7%)
KOSM 6.48 Increased By ▲ 0.42 (6.93%)
MLCF 98.75 Increased By ▲ 1.08 (1.11%)
NBP 206.92 Increased By ▲ 0.31 (0.15%)
PACE 11.67 Decreased By ▼ -0.09 (-0.77%)
PAEL 42.95 Decreased By ▼ -0.61 (-1.4%)
PIAHCLA 27.34 Decreased By ▼ -0.61 (-2.18%)
PIBTL 18.43 Increased By ▲ 0.08 (0.44%)
PPL 245.58 Increased By ▲ 6.69 (2.8%)
PRL 37.18 Increased By ▲ 0.91 (2.51%)
PTC 67.25 Decreased By ▼ -0.74 (-1.09%)
SEARL 96.31 Decreased By ▼ -1.69 (-1.72%)
SSGC 31.41 Increased By ▲ 0.98 (3.22%)
TELE 9.54 No Change ▼ 0.00 (0%)
THCCL 68.01 Decreased By ▼ -0.68 (-0.99%)
TPLP 11.17 Decreased By ▼ -0.10 (-0.89%)
TREET 26.74 Increased By ▲ 0.49 (1.87%)
TRG 69.96 Decreased By ▼ -0.46 (-0.65%)
WAVES 11.27 Decreased By ▼ -0.13 (-1.14%)
WTL 1.29 No Change ▼ 0.00 (0%)
World

Swedish health agency extends pause on J&J vaccine

  • "We think it is better to recommend the vaccines that healthcare is now used to using," Chief Epidemiologist Anders Tegnell said in a statement.
  • The agency said on April 14 it would not start using the COVID-19 vaccine following reports of rare blood clots, similar to those reported for the AstraZeneca shot.
Published April 23, 2021 Updated April 23, 2021 06:04pm
By

STOCKHOLM: Sweden's Public Health Agency said on Monday it was extending its recommendation against beginning vaccinations using the COVID-19 vaccine made by Johnson & Johnson.

The agency said the vaccine could be given to people aged 65 and above but that this group would already be inoculated with other vaccines by the time the Johnson & Johnson vaccine was delivered to Sweden in substantial quantities.

"We think it is better to recommend the vaccines that healthcare is now used to using," Chief Epidemiologist Anders Tegnell said in a statement.

The agency said on April 14 it would not start using the COVID-19 vaccine following reports of rare blood clots, similar to those reported for the AstraZeneca shot.

Comments

Comments are closed for this article.